CR9545A - Metodos para sintetizar derivados de 6-alquilaminoquinolina - Google Patents
Metodos para sintetizar derivados de 6-alquilaminoquinolinaInfo
- Publication number
- CR9545A CR9545A CR9545A CR9545A CR9545A CR 9545 A CR9545 A CR 9545A CR 9545 A CR9545 A CR 9545A CR 9545 A CR9545 A CR 9545A CR 9545 A CR9545 A CR 9545A
- Authority
- CR
- Costa Rica
- Prior art keywords
- methods
- alquilaminoquinolina
- synthesizing derivatives
- directed
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invencion esta dirigida a un metodo para sintetizar compuestos de Formula (I), en donde X, Z, V, R1, R3, R4, G2, n, x, y, yz son como se define aqui. Esta invencion tambien incluye un metodo para preparar compuestos de acido de Formula (VII), en donde R es H, y R4, x, y, yz son como se define aqui y PG es un grupo protector. Esta invencion esta tambien dirigida a (E) N-{4-[3-cloro-4-(2-piridinilmetoxi)anilino]-3-ciano-7-etoxi-6-quinolinil}-4-(metilamino)-2-butenamida, composiciones que contienen estos metodos para utilizar en el tratamiento del cancer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68504005P | 2005-05-25 | 2005-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9545A true CR9545A (es) | 2008-01-10 |
Family
ID=36794434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9545A CR9545A (es) | 2005-05-25 | 2007-11-23 | Metodos para sintetizar derivados de 6-alquilaminoquinolina |
Country Status (20)
Country | Link |
---|---|
US (1) | US20060270670A1 (es) |
EP (1) | EP1883630A2 (es) |
JP (1) | JP2008542266A (es) |
KR (1) | KR20080016604A (es) |
CN (1) | CN101180273A (es) |
AR (1) | AR054192A1 (es) |
AU (1) | AU2006249596A1 (es) |
BR (1) | BRPI0610142A2 (es) |
CA (1) | CA2608589A1 (es) |
CR (1) | CR9545A (es) |
GT (1) | GT200600215A (es) |
IL (1) | IL187301A0 (es) |
MX (1) | MX2007014774A (es) |
NO (1) | NO20075726L (es) |
PA (1) | PA8676301A1 (es) |
PE (1) | PE20070007A1 (es) |
RU (1) | RU2007140957A (es) |
TW (1) | TW200716556A (es) |
WO (1) | WO2006127203A2 (es) |
ZA (1) | ZA200710143B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070135499A1 (en) * | 2005-07-11 | 2007-06-14 | Aerie Pharmaceuticals, Inc. | Hydrazide compounds |
WO2007008926A1 (en) * | 2005-07-11 | 2007-01-18 | Aerie Pharmaceuticals, Inc. | Isoquinoline compounds |
CA2664335C (en) | 2006-09-20 | 2014-12-02 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
US8455513B2 (en) | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
US8455514B2 (en) * | 2008-01-17 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-and 7-amino isoquinoline compounds and methods for making and using the same |
WO2009151910A2 (en) * | 2008-05-25 | 2009-12-17 | Wyeth | Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer |
US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
EP3828172A1 (en) | 2009-05-01 | 2021-06-02 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
JP5622842B2 (ja) | 2009-05-14 | 2014-11-12 | コーロン ライフ サイエンス インク | アルキルアミン誘導体の製造方法 |
PL2621923T3 (pl) | 2010-09-29 | 2017-08-31 | Intervet International B.V. | Związki n-heteroarylu z mostkami cyklicznymi do leczenia chorób pasożytniczych |
BR112013006030B1 (pt) | 2010-09-29 | 2020-03-17 | Intervet International B.V. | Composto e sais ou n-óxidos farmaceuticamente aceitáveis, e, uso do composto |
CN102649778A (zh) * | 2011-02-23 | 2012-08-29 | 苏州波锐生物医药科技有限公司 | 喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途 |
WO2013152135A1 (en) * | 2012-04-04 | 2013-10-10 | Dawei Zhang | Substituted quinolines as bruton's tyrosine kinases inhibitors |
ES2852377T3 (es) | 2013-03-15 | 2021-09-13 | Aerie Pharmaceuticals Inc | Sales dimesilato de 4-(3-amino-1-(isoquinolin-6-ilamino)-1-oxopropan-2-il)bencilo, sus combinaciones con prostaglandinas y el uso de las mismas en el tratamiento de trastornos oculares |
WO2014177038A1 (en) * | 2013-04-28 | 2014-11-06 | Sunshine Lake Pharma Co., Ltd. | Aminoquinazoline derivatives and their salts and methods of use thereof |
US9643927B1 (en) | 2015-11-17 | 2017-05-09 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
JP6832946B2 (ja) | 2015-11-17 | 2021-02-24 | アエリエ ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤およびその中間体の調製方法 |
TWI739825B (zh) * | 2016-04-28 | 2021-09-21 | 大陸商江蘇恆瑞醫藥股份有限公司 | 一種製備酪胺酸激酶抑制劑及其衍生物的方法 |
MX2019002396A (es) | 2016-08-31 | 2019-07-08 | Aerie Pharmaceuticals Inc | Composiciones oftalmicas. |
CN110506037A (zh) | 2017-03-31 | 2019-11-26 | 爱瑞制药公司 | 芳基环丙基-氨基-异喹啉酰胺化合物 |
US11427563B2 (en) | 2018-09-14 | 2022-08-30 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
US6288082B1 (en) * | 1998-09-29 | 2001-09-11 | American Cyanamid Company | Substituted 3-cyanoquinolines |
US6297258B1 (en) * | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
ES2248302T3 (es) * | 2000-03-13 | 2006-03-16 | Wyeth Holdings Corporation | Utilizacion de cianoquinolinas para el tratamiento o la inhibicion de polipos colonicos. |
UA77200C2 (en) * | 2001-08-07 | 2006-11-15 | Wyeth Corp | Antineoplastic combination of cci-779 and bkb-569 |
BR0307375A (pt) * | 2002-02-05 | 2004-12-07 | Wyeth Corp | Processo para a sìntese de ácidos n-acil-2-amino-4-alcóxi-5-nitro-benzóicos |
CL2004000016A1 (es) * | 2003-01-21 | 2005-04-15 | Wyeth Corp | Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina. |
JP2007502819A (ja) * | 2003-08-19 | 2007-02-15 | ワイス・ホールディングズ・コーポレイション | 4−アミノ−3−キノリンカルボニトリルの調製方法 |
BRPI0520812A2 (pt) * | 2004-01-16 | 2009-10-06 | Wyeth Corp | método para preparar um composto de quinolina 4-substituìda, e, composto |
-
2006
- 2006-04-26 MX MX2007014774A patent/MX2007014774A/es unknown
- 2006-04-26 BR BRPI0610142-9A patent/BRPI0610142A2/pt not_active IP Right Cessation
- 2006-04-26 CA CA002608589A patent/CA2608589A1/en not_active Abandoned
- 2006-04-26 KR KR1020077028377A patent/KR20080016604A/ko not_active Application Discontinuation
- 2006-04-26 RU RU2007140957/04A patent/RU2007140957A/ru not_active Application Discontinuation
- 2006-04-26 AU AU2006249596A patent/AU2006249596A1/en not_active Abandoned
- 2006-04-26 CN CNA2006800177664A patent/CN101180273A/zh active Pending
- 2006-04-26 EP EP06751575A patent/EP1883630A2/en not_active Withdrawn
- 2006-04-26 WO PCT/US2006/015931 patent/WO2006127203A2/en active Application Filing
- 2006-04-26 JP JP2008513496A patent/JP2008542266A/ja not_active Withdrawn
- 2006-05-04 TW TW095115892A patent/TW200716556A/zh unknown
- 2006-05-18 AR ARP060102011A patent/AR054192A1/es unknown
- 2006-05-22 PE PE2006000538A patent/PE20070007A1/es not_active Application Discontinuation
- 2006-05-24 GT GT200600215A patent/GT200600215A/es unknown
- 2006-05-25 US US11/442,562 patent/US20060270670A1/en not_active Abandoned
- 2006-05-25 PA PA20068676301A patent/PA8676301A1/es unknown
-
2007
- 2007-11-09 NO NO20075726A patent/NO20075726L/no not_active Application Discontinuation
- 2007-11-11 IL IL187301A patent/IL187301A0/en unknown
- 2007-11-23 CR CR9545A patent/CR9545A/es not_active Application Discontinuation
- 2007-11-26 ZA ZA200710143A patent/ZA200710143B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200710143B (en) | 2008-11-26 |
NO20075726L (no) | 2008-02-04 |
CN101180273A (zh) | 2008-05-14 |
AU2006249596A1 (en) | 2006-11-30 |
WO2006127203A2 (en) | 2006-11-30 |
PE20070007A1 (es) | 2007-02-12 |
TW200716556A (en) | 2007-05-01 |
AR054192A1 (es) | 2007-06-06 |
KR20080016604A (ko) | 2008-02-21 |
WO2006127203A3 (en) | 2007-05-03 |
BRPI0610142A2 (pt) | 2011-01-04 |
IL187301A0 (en) | 2008-04-13 |
MX2007014774A (es) | 2008-02-19 |
EP1883630A2 (en) | 2008-02-06 |
US20060270670A1 (en) | 2006-11-30 |
CA2608589A1 (en) | 2006-11-30 |
GT200600215A (es) | 2006-12-26 |
JP2008542266A (ja) | 2008-11-27 |
RU2007140957A (ru) | 2009-06-27 |
PA8676301A1 (es) | 2009-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR9545A (es) | Metodos para sintetizar derivados de 6-alquilaminoquinolina | |
ATE469892T1 (de) | Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung | |
AR061924A1 (es) | Proceso para elaborar 2- amino -5 - halobenzamidas 3- sustituidas | |
BRPI0507495A (pt) | composto, composição farmacêutica, uso do composto método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5 | |
HK1167658A1 (en) | Composition for the preparation of 17-vinyl- triflates as intermediates 17-- | |
HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
DE602005018238D1 (de) | Halbsynthetisches verfahren zur herstellung von 10-desacetyl-n-desbenzoyl-paclitaxel | |
AR055882A1 (es) | Un producto mejorado para preparar cabergolina | |
PL362766A1 (en) | Novel imidazole derivatives, production method thereof and use thereof | |
AR057451A1 (es) | Metodos para preparar derivados de acido glutamico | |
UY29498A1 (es) | Derivados de aminoácidos | |
PT1606288E (pt) | Derivados de benzenossulfonamida, processo para a sua preparação e a sua utilização para tratamento da dor | |
PL376896A1 (pl) | Sposoby wytwarzania 5-androstenów podstawionych w pozycji C-7 | |
UY30673A1 (es) | Derivados 6, 7 y 8 sustituidos del acido (3r)-5-oxo-2,3-dihidro-5h-tiazolo[3,2a]piridin-3-carboxilico, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
TW200504025A (en) | Organic compounds | |
BR0311810A (pt) | Preparação revestida, processo para a produção e uso da mesma, processo para a produção de pelo menos uma ração e/ou aditivo para rações contendo pelo menos um diformiato, e, ração para animais | |
ES2164293T3 (es) | Procedimiento para la fabricacion de pigmentos amarillos de oxido de hierro y su uso. | |
PE20060951A1 (es) | Proceso sintetico para la preparacion de compuestos aromaticos biciclicos | |
AR053597A1 (es) | Procedimiento para fabricar derivados 4-azaesteroide fluorados | |
GT200600380A (es) | Proceso para la preparacion de inhibidores de beta-lactamasa | |
DE60215193D1 (de) | Stereoselektives verfahren zur herstellung von 6alpha-fluorpregnanen und zwischenprodukten | |
ES2167777T3 (es) | Procedimiento para la preparacion de paclitaxel. | |
PL353291A1 (en) | Novel compounds, method of obtaining them, their application as pigments and composition containing them | |
BR0113944A (pt) | Processo para a produção de compostos quirais | |
DE60137352D1 (de) | Nsalze, verfahren zur herstellung von beiden und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |